Innovation
We continuously create new approaches, applications, and AI-powered tools to help clients anticipate change, unlock sharper insights, and shape stronger Market Access strategies.
We are an international team of experienced consultants from established strategy firms and AI specialists with a strong background in life sciences. We have contributed to the clinical development, value maximization and launch of more than 50 drugs — including some of today's most successful blockbusters.
Meet our team
We believe every innovative product deserves a custom-made, boundary-pushing approach — where our “brains” meet AI-powered “brawn” to maximize impact. We harness the unique synergy of our market access strategists and AI engineers to focus on high-value activities while delegating low-value tasks to AI.
Our advanced market access and pricing tools, seamlessly integrating AI and big data, generate deeper insights on the strategies that will create value in the future.
We have built an internal team of developers dedicated to our applications and AI tools. Working closely with our Market Access consultants, they have developed a deep understanding of Market Access concepts, business requirements, and real-world use cases.
Whether it's looking for analogs or developing value stories, our AI tools are built for real-world applications — mapping HTA outcomes, finding relevant analogs against any criteria, or scanning the clinical-trial landscape.
We assembled an elite team of renowned local pricing and reimbursement specialists, payers, key opinion leaders, and negotiation specialists. Our approach to collaborating and engaging with our experts is unique — we challenge conventional thinking to go beyond the obvious solutions.
Our values reflect who we are and how we work — combining innovation, excellence, and a global perspective to deliver meaningful impact for our clients.
We continuously create new approaches, applications, and AI-powered tools to help clients anticipate change, unlock sharper insights, and shape stronger Market Access strategies.
We put client satisfaction first, combining strategic rigor, high-quality deliverables, and pragmatic recommendations to generate measurable value and support better business decisions.
We support global teams with deep US and ex-US expertise, reflected in the diversity of our nationalities — helping clients navigate interconnected markets and optimize value in an MFN world.
Elevio Group was founded by former partners from a big 4 company and leading strategy consulting firms, united by a shared passion for Market Access strategy.
They wanted to create a more agile, flexible, and specialized model — bringing together some of the best Market Access experts to address complex global challenges.
Their ambition was to build a global leader in the field, combining deep US and ex-US expertise with the freedom to innovate.
From the start, Elevio Group was designed to deliver sharper strategic thinking, stronger client impact, and new technology- and AI-enabled solutions for the future of Market Access.
0+
Projects completed
0+
Product launches
0+
Clinical trials informed
0+
Global and local experts
0%
Recurring clients
$0B
Total peak sales advised